Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CUBICStars is a Japanese biotechnology company specializing in advanced 3D tissue clearing and whole-organ imaging technologies. Founded by Dr. Taketo Shinoda and based on research from the University of Tokyo and RIKEN, the company utilizes its proprietary CUBIC platform to provide high-resolution, three-dimensional visualization of biological structures. The CUBIC technology allows for the rapid clearing of tissues, making them transparent for light-sheet microscopy and enabling the comprehensive analysis of cellular distributions and vascular networks within intact organs. CUBICStars offers contract research services and specialized reagents to pharmaceutical companies and academic institutions to accelerate drug discovery and basic research. Their solutions are particularly valuable in neuroscience and oncology for overcoming the limitations and sampling biases of traditional 2D histological sectioning.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shinoda Taketo.